Atar Baer1, Meaghan S Fagalde1, Curtis D Drake1, Elisabeth H Sohlberg1, Elizabeth Barash1, Sara Glick2, Alexander J Millman3, Jeffrey S Duchin1,2,4. 1. Public Health-Seattle & King County, Seattle, WA, USA. 2. Division of Allergy and Infectious Diseases, School of Medicine, University of Washington, Seattle, WA, USA. 3. Division of Viral Hepatitis, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA. 4. School of Public Health, University of Washington, Seattle, WA, USA.
Abstract
INTRODUCTION: With the goal of eliminating hepatitis C virus (HCV) as a public health problem in Washington State, Public Health-Seattle & King County (PHSKC) designed a Hepatitis C Virus Test and Cure (HCV-TAC) data system to integrate surveillance, clinical, and laboratory data into a comprehensive database. The intent of the system was to promote identification, treatment, and cure of HCV-infected persons (ie, HCV care cascade) using a population health approach. MATERIALS AND METHODS: The data system automatically integrated case reports received via telephone and fax from health care providers and laboratories, hepatitis test results reported via electronic laboratory reporting, and data on laboratory and clinic visits reported by 6 regional health care systems. PHSKC examined patient-level laboratory test results and established HCV case classification using Council of State and Territorial Epidemiologists criteria, classifying patients as confirmed if they had detectable HCV RNA. RESULTS: The data enabled PHSKC to report the number of patients at various stages along the HCV care cascade. Of 7747 HCV RNA-positive patients seen by a partner site, 5377 (69%) were assessed for severity of liver fibrosis, 3932 (51%) were treated, and 2592 (33%) were cured. PRACTICE IMPLICATIONS: Data supported local public heath surveillance and HCV program activities. The data system could serve as a foundation for monitoring future HCV prevention and control programs.
INTRODUCTION: With the goal of eliminating hepatitis C virus (HCV) as a public health problem in Washington State, Public Health-Seattle & King County (PHSKC) designed a Hepatitis C Virus Test and Cure (HCV-TAC) data system to integrate surveillance, clinical, and laboratory data into a comprehensive database. The intent of the system was to promote identification, treatment, and cure of HCV-infected persons (ie, HCV care cascade) using a population health approach. MATERIALS AND METHODS: The data system automatically integrated case reports received via telephone and fax from health care providers and laboratories, hepatitis test results reported via electronic laboratory reporting, and data on laboratory and clinic visits reported by 6 regional health care systems. PHSKC examined patient-level laboratory test results and established HCV case classification using Council of State and Territorial Epidemiologists criteria, classifying patients as confirmed if they had detectable HCV RNA. RESULTS: The data enabled PHSKC to report the number of patients at various stages along the HCV care cascade. Of 7747 HCV RNA-positive patients seen by a partner site, 5377 (69%) were assessed for severity of liver fibrosis, 3932 (51%) were treated, and 2592 (33%) were cured. PRACTICE IMPLICATIONS: Data supported local public heath surveillance and HCV program activities. The data system could serve as a foundation for monitoring future HCV prevention and control programs.
Entities:
Keywords:
electronic health records; hepatitis C; information systems; public health; surveillance
Authors: Megan G Hofmeister; Elizabeth M Rosenthal; Laurie K Barker; Eli S Rosenberg; Meredith A Barranco; Eric W Hall; Brian R Edlin; Jonathan Mermin; John W Ward; A Blythe Ryerson Journal: Hepatology Date: 2018-11-06 Impact factor: 17.425
Authors: Bryce D Smith; Rebecca L Morgan; Geoff A Beckett; Yngve Falck-Ytter; Deborah Holtzman; Chong-Gee Teo; Amy Jewett; Brittney Baack; David B Rein; Nita Patel; Miriam Alter; Anthony Yartel; John W Ward Journal: MMWR Recomm Rep Date: 2012-08-17
Authors: John D Scott; Kent T Unruh; Mary C Catlin; Joseph O Merrill; David J Tauben; Roger Rosenblatt; Dedra Buchwald; Ardith Doorenbos; Cara Towle; Christian B Ramers; David H Spacha Journal: J Telemed Telecare Date: 2012-12-03 Impact factor: 6.184
Authors: James W Galbraith; John P Donnelly; Ricardo A Franco; Edgar T Overton; Joel B Rodgers; Henry E Wang Journal: Clin Infect Dis Date: 2014-06-09 Impact factor: 9.079
Authors: Jason Zucker; Justin G Aaron; Daniel J Feller; Jacek Slowikowski; Henry Evans; Matthew L Scherer; Michael T Yin; Peter Gordon Journal: Open Forum Infect Dis Date: 2018-07-03 Impact factor: 3.835
Authors: John Scott; Meaghan Fagalde; Atar Baer; Sara Glick; Elizabeth Barash; Hilary Armstrong; Kris V Kowdley; Matthew R Golden; Alexander J Millman; Noele P Nelson; Lauren Canary; Matthew Messerschmidt; Pallavi Patel; Michael Ninburg; Jeff Duchin Journal: Hepatol Commun Date: 2020-11-07